Underrepresentation of the elderly in clinical trials, time for action

Editorial calls on pharmaceutical companies to stop using debatable inclusion and exclusion criteria and design trials in a way that encourages elderly people to participate and on regulatory authorities to be stricter in their evaluation of registration dossiers.

British Journal of Clinical Pharmacology